These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 14730100)

  • 1. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the antidepressant mirtazapine in vitro: contribution of cytochromes P-450 1A2, 2D6, and 3A4.
    Störmer E; von Moltke LL; Shader RI; Greenblatt DJ
    Drug Metab Dispos; 2000 Oct; 28(10):1168-75. PubMed ID: 10997935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
    Kot M; Daniel WA
    Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.
    Kot M; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2007; 59(6):727-33. PubMed ID: 18195463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver.
    Haduch A; Wójcikowski J; Daniel WA
    Pharmacol Rep; 2005; 57(6):774-81. PubMed ID: 16382196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
    Daniel WA; Haduch A; Syrek M; Boksa J
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
    Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
    Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.
    Nielsen KK; Flinois JP; Beaune P; Brøsen K
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1659-64. PubMed ID: 8667235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT; Chang YW; Lan SJ; Yeh TK
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
    Wójcikowski J; Haduch A; Daniel WA
    Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A; Wójcikowski J; Daniel WA
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.